Worldwide Trends in HVC Therapy Analyzed in New FirstWord Report Available at MarketPublishers.com
10 Jan 2013 • by Natalie Aster
LONDON – The global hepatitis C market is expected to reach almost USD 15 billion in 2020. In 2011, the market was estimated at about USD 4 billion. The market participants are in search for new effective treatment methods and innovative drugs. The hepatitis C drugs market is constantly growing in line with development of new production technologies and increasing effectiveness of HVC drugs. The hepatitis C market registers the most rapid growth in the Asia Pacific, the Middle East, and Latin America.
The population growth, obesity problems, the rising number of HVC drug users are amid the factors contributing to the growth of the global hepatitis C market.
New report “Therapy Trends Consensus Outlook: Hepatitis C” created by FirstWord offers detailed examination of trends in the HVC therapy. It delves deep into factors affecting the hepatitis C market. The study includes relevant data on HCV sales in 2006-2011 and forecasts HCV sales up to 2020. An all-inclusive consensus forecast, data on key competitors and drug developers as well as current and late-stage pipeline drugs can be found in the report too.
Therapy Trends Consensus Outlook: Hepatitis C
Published: December 1, 2012
Price: US$ 4,995.00
More FirstWord the pharmaceutical industry related research reports by FirstWord are Available:
- Social and Mobile Pharma - the State of the Digital Landscape
- The Rise of Health Outcome Liaison Teams
- KOL Insight: Hepatitis C: the Race for the First Interferon-free Regimen
More insightful market research reports by the publisher can be found at FirstWord page.